Human NFKB-p65(Nuclear Factor Kappa B p65) ELISA Kit
中文名称：人核因子κB亚基p65(NFKB-p65)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 0.16-10 ng/mL
- 灵敏度： 0.1 ng/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人NFKB-p65抗体包被于酶标板上，实验时样品（或标准品）中的人NFKB-p65会与包被抗体结合。后依次加入生物素化的抗人NFKB-p65抗体和辣根过氧化物酶标记的亲和素，抗人NFKB-p65抗体与结合在包被抗体上的人NFKB-p65结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，NFKB-p65浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中NFKB-p65的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 0.16-10 ng/mL |
| 灵敏度 | 0.1 ng/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人NFKB-p65，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Beta-Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF-κB Pathways
IF: 6.100 -
Insight into the molecular mechanism of anti-breast cancer therapeutic potential of substituted salicylidene-based compounds using cell-based assays and molecular docking studies
IF: 4.200 -
PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis
IF: 3.400 -
The relationship between Nuclear Factor-Kappa B and Inhibitor-Kappa B parameters with clinical course in COVID-19 patients
IF: 2.600Journal： MOLECULAR BIOLOGY REPORTS (2024)Reactivity：HumanSample Type：serum -
Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma
IF: 7.700 -
PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
IF: 5.600 -
Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds
IF: 5.600Journal： INTERNATIONAL IMMUNOPHARMACOLOGY (2023)Reactivity：HumanSample Type：Serum -
The Association between Serum 25-Hydroxyvitamin D3 Levels and Pro-Inflammatory Markers in New-Onset Type 2 Diabetes Mellitus and Prediabetes
IF: 5.500 -
Polyethyleneglycol-Betulinic Acid (PEG-BA) Polymer-Drug Conjugate Induces Apoptosis and Antioxidation in a Biological Model of Pancreatic Cancer
IF: 5.000 -
Low-dose 5-aza-2′-deoxycytidine protects against early renal injury by increasing klotho expression
IF: 3.800
实验操作视频
